Status:
UNKNOWN
Conservative Treatment for Atypical Endometrial Hyperplasia and Early Endometrial Cancer
Lead Sponsor:
Beijing Obstetrics and Gynecology Hospital
Conditions:
Atypical Endometrial Hyperplasia and Endometrial Cancer
Eligibility:
FEMALE
18-45 years
Brief Summary
Exploring the efficacy and pregnancy outcomes of conservative treatment for atypical endometrial hyperplasia and endometrial cancer. Study the factors related to predicting treatment efficacy.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- (1) age ≤ 45 years old, strong desire to preserve reproductive function, and no factors of reproductive dysfunction evaluated before treatment; (2) The pathological type is atypical endometrial hyperplasia or endometrial cancer; (3) Imaging examination confirmed that the tumor was localized to the endometrium; (4) There are follow-up conditions available.
Exclusion
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06170684
Start Date
December 1 2023
End Date
January 1 2024
Last Update
December 14 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.